3.
TSLC1 mRNA与4.1B mRNA的表达与NSCLC患者临床特征的关系
The relationship between the expressions of TSLC1 mRNA and 4.1B mRNA and the clinical features
| Clinical features | n | Expression of TSLC1 mRNA | Expression of 4.1B mRNA | |||||
| Relative expression level | t (F) | P | Relative expression level | t (F) | P | |||
| Gender | -0.470 | 0.640 | 0.547 | 0.587 | ||||
| Male | 33 | 0.346±0.059 | 0.211±0.040 | |||||
| Female | 19 | 0.354±0.051 | 0.205±0.041 | |||||
| Age | 0.136 | 0.892 | -0.160 | 0.874 | ||||
| ≥55y | 32 | 0.350±0.051 | 0.208±0.038 | |||||
| < 55y | 20 | 0.347±0.063 | 0.210±0.045 | |||||
| Pathology | 1.455 | 0.152 | 0.582 | 0.563 | ||||
| Squamous cell carcinoma | 29 | 0.359±0.057 | 0.212±0.039 | |||||
| Adenocarcinoma | 23 | 0.336±0.052 | 0.205±0.041 | |||||
| Differentiation | 5.029 | 0.010 | 11.032 | < 0.001 | ||||
| Well | 17 | 0.378±0.048 | 0.233±0.032 | |||||
| Moderate | 23 | 0.345±0.061 | 0.210±0.038 | |||||
| Poor | 12 | 0.317±0.032 | 0.173±0.029 | |||||
| TNM stage | 15.217 | < 0.001 | 16.270 | < 0.001 | ||||
| Ⅰ | 15 | 0.394±0.044 | 0.244±0.031 | |||||
| Ⅱ | 24 | 0.348±0.050 | 0.205±0.034 | |||||
| Ⅲ | 13 | 0.301±0.032 | 0.176±0.027 | |||||